Ravinder Wali, MD
Basic profileRavinder Wali is a Nephrology physician affiliated with UMass Memorial Health Care. OpenAlex indexes 44 publications with 3,101 citations (h-index 22); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.
Sponsor: Inova Health Care Services
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Veloxis Pharmaceuticals, Inc.Program year20231 payment$45
- Mallinckrodt Hospital Products Inc.Program year20212 payments$67
- Vifor Pharma, Inc.Program year20211 payment$43
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
46.6%Beta blocker14.2%Carvedilol42%Labetalol Hcl29%Metoprolol Succinate18%Metoprolol Tartrate12%Part D<11 patientsCalcium channel blocker11.4%Amlodipine Besylate100%Part D≥23 patients+ 7 more classes in this area
Metabolism & gastrointestinal
31.9%Proton pump inhibitor9.3%Pantoprazole Sodium76%Omeprazole24%Part D<11 patientsCorticosteroid7.3%Prednisone100%Part D≥15 patients+ 5 more classes in this area
Anti-infectives
6.7%Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor4.1%Valganciclovir Hcl100%Part D<11 patientsShort-acting sulfonamides2.5%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Stefanie Lowas, MD
UMass Memorial Health Care
David Keefe, MD
UMass Memorial Health Care
Anthony Rothschild, MD
UMass Memorial Health Care
Tiffany Moore-Simas, MD
UMass Memorial Health Care
Laura Svetkey, MD
Duke University
Prasad Devarajan, MD
Cincinnati Children's Hospital Medical Center
Rajesh V. Thakker
Queen Mary University of London
Paul Kimmel, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”